Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Nexgard successfully treated a husky's demodicosis.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

Bortezomib chemotherapy can cause temporary skin rashes.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.